1. Home
  2. NWBI vs ANIP Comparison

NWBI vs ANIP Comparison

Compare NWBI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWBI
  • ANIP
  • Stock Information
  • Founded
  • NWBI 1896
  • ANIP 2001
  • Country
  • NWBI United States
  • ANIP United States
  • Employees
  • NWBI N/A
  • ANIP N/A
  • Industry
  • NWBI Major Banks
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWBI Finance
  • ANIP Health Care
  • Exchange
  • NWBI Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • NWBI 1.8B
  • ANIP 2.0B
  • IPO Year
  • NWBI N/A
  • ANIP N/A
  • Fundamental
  • Price
  • NWBI $12.17
  • ANIP $90.83
  • Analyst Decision
  • NWBI Buy
  • ANIP Strong Buy
  • Analyst Count
  • NWBI 2
  • ANIP 7
  • Target Price
  • NWBI $15.00
  • ANIP $99.14
  • AVG Volume (30 Days)
  • NWBI 861.7K
  • ANIP 277.7K
  • Earning Date
  • NWBI 10-27-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • NWBI 6.41%
  • ANIP N/A
  • EPS Growth
  • NWBI 39.35
  • ANIP N/A
  • EPS
  • NWBI 1.12
  • ANIP N/A
  • Revenue
  • NWBI $561,855,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • NWBI $6.98
  • ANIP $39.51
  • Revenue Next Year
  • NWBI $11.67
  • ANIP $9.58
  • P/E Ratio
  • NWBI $11.14
  • ANIP N/A
  • Revenue Growth
  • NWBI 14.22
  • ANIP 38.68
  • 52 Week Low
  • NWBI $10.75
  • ANIP $52.50
  • 52 Week High
  • NWBI $15.42
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • NWBI 46.47
  • ANIP 49.49
  • Support Level
  • NWBI $12.05
  • ANIP $87.60
  • Resistance Level
  • NWBI $12.74
  • ANIP $92.56
  • Average True Range (ATR)
  • NWBI 0.26
  • ANIP 2.18
  • MACD
  • NWBI -0.00
  • ANIP -0.41
  • Stochastic Oscillator
  • NWBI 34.67
  • ANIP 59.32

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: